Development and production of glucose monitoring, insulin delivery, and digital diabetes management solutions
Roche Diabetes Care Deutschland GmbH
Rotkreuz (CH) · Basel (CH) · Mannheim (DE) · Penzberg (DE) · Ludwigsburg (DE) · Indianapolis (US) · Pleasanton (US)New on Amplifa
About Roche Diabetes Care
Roche Diabetes Care is a business unit of the Diagnostics Division of Roche Holding AG and has been developing technologies and services for diabetes management for over 40 years. The portfolio includes glucose monitoring, insulin delivery (insulin pumps and injection aids), and digital solutions such as the RocheDiabetes Care Platform under the brands Accu-Chek and mySugr. The goal is Integrated Personalized Diabetes Management (iPDM), which connects measurement, therapy, and data analysis. Research, development, and production of diabetes and point-of-care devices, as well as the European central warehouse, are located at the Mannheim site (formerly Boehringer Mannheim). The main site of Roche Diagnostics International AG is in Rotkreuz (Gemeinde Risch), while the headquarters of Roche Diabetes Care is in Basel. Other locations include Penzberg, Ludwigsburg, Indianapolis, and Pleasanton (USA). Distribution is worldwide, with direct supply to many European countries from Mannheim.
- Site
- Rotkreuz (Gemeinde Risch)
- Processes
- Glucose Monitoring (Blood Sugar Self-Control), Insulin Delivery (Insulin Pumps), Needle Aid Production, Production of Blood Gas Analyzers (former Graz site, until 2014), Production of Diabetes and Point-of-Care Devices, PCR-based Molecular Diagnostics, Fully Automated Tissue-Based Cancer Diagnostics (Ventana), Modular Instrument Systems for Clinical Chemistry and Immuno-chemistry
- Materials
- Integrated Personalized Diabetes Management, Point-of-Care and Patient Self-Testing, PCR-based Molecular Diagnostics
- Founded
- 1896 (Roch
- Employees
- 5,500 (Roche Diabete
- Industries
- Diabetes Care, Medical Technology, In Vitro Diagnostics, Healthcare
- 01
Research and Development
- 02
Production of Diabetes and Point-of-Care Devices
- 03
Central Warehouse and Logistics from Mannheim
- 04
Direct Supply to European Companies
- 05
Service and Services for Diabetics
Solutions and Technologies
Integrated Personalized Diabetes Management
Interconnecting glucose monitoring, insulin delivery, and digital data analysis into a complete system.
Point-of-Care and Patient Self-Testing
Instrument systems for fast, reliable diagnostics in clinic, practice, and self-monitoring.
PCR-based Molecular Diagnostics
Diagnostic systems under the brands Cobas and LightCycler for oncology, microbiology, and virology.
Sites
Mannheim
DER&D and Production of Diabetes/Point-of-Care Devices, Central Warehouse Europe
Rotkreuz
CHMain Site of Roche Diagnostics
Basel
CHHeadquarters of Roche Diabetes Care
Penzberg
DEBiotech Center, Branch Office
Ludwigsburg
DEBranch Office
Indianapolis
USResearch and Development
Pleasanton
USR&D, Headquarters of Molecular Diagnostics
Products and Systems
Inside the production
Industries
Processes & technical limits
| Processes | Tolerance | Max. part | Weight | Lot size | Materials |
|---|---|---|---|---|---|
| Glucose Monitoring (Blood Sugar Self-Control)Testing | – | – | – | – | – |
| Insulin Delivery (Insulin Pumps)Assembly | – | – | – | – | – |
| Needle Aid ProductionAssembly | – | – | – | – | – |
| Production of Blood Gas Analyzers (former Graz site, until 2014)Assembly | – | – | – | – | – |
| Production of Diabetes and Point-of-Care DevicesAssembly | – | – | – | – | – |
| PCR-based Molecular DiagnosticsTesting | – | – | – | – | – |
| Fully Automated Tissue-Based Cancer Diagnostics (Ventana)Testing | – | – | – | – | – |
| Modular Instrument Systems for Clinical Chemistry and Immuno-chemistryTesting | – | – | – | – | – |
| Decentralised Testing (Point of Care) and Patient Self TestingTesting | – | – | – | – | – |
| Tissue/Haematology/Urine Diagnostics and Coagulation TestingTesting | – | – | – | – | – |
| Workflow Automation, Data Analysis, and Decision SupportEngineering | – | – | – | – | – |
Additional services
History
- 1896
Founding of F. Hoffmann-La Roche by Fritz Hoffmann-La Roche
- 1998
Acquisition of Corange Ltd (Boehringer Mannheim); Rebranding to Roche Diagnostics
- 2013
Introduction of the Sequencing unit; Dissolution of the Applied Science business unit
- 2014
Relocation of the Graz site (blood gas analyzers) to Rotkreuz
- 2020
Cooperation with Diabeloop for further development of insulin pump therapy; Introduction of a COVID-19 rapid test
- 2023
Matt Sause takes over the CEO function of the Diagnostics division from Thomas Schinecker